Literature DB >> 20976737

Rapid screening of ATP13A2 variant with high-resolution melting analysis.

Manabu Funayama1, Hiroyuki Tomiyama, Ruey-Meei Wu, Kotaro Ogaki, Hiroyo Yoshino, Yoshikuni Mizuno, Nobutaka Hattori.   

Abstract

Several genetic and environmental factors are involved in the pathogenesis of Parkinson's disease (PD). Recently, a novel variant of ATP13A2 (p.A746T) responsible for PARK9 was reported as a risk factor for PD in the Han-Chinese population. To investigate the role of this variant in Japanese PD patients, we examined 917 Japanese PD patients (871 index cases) and 190 controls by high-resolution melting curve analysis. We detected heterozygous p.A746T variant in a single patient with sporadic PD and a single control subject. These results suggest that ATP13A2 p.A746T variant is unlikely to play a role as a common risk factor or a pathogenic mutation for PD at least in Japanese. Our data on Japanese differ from those reported recently on Han-Chinese. Further studies are needed to confirm conclusions on roles of ATP13A2 variant in Asians or other populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20976737     DOI: 10.1002/mds.23106

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  ATP13A2 deficiency disrupts lysosomal polyamine export.

Authors:  Sarah van Veen; Shaun Martin; Chris Van den Haute; Veronick Benoy; Joseph Lyons; Roeland Vanhoutte; Jan Pascal Kahler; Jean-Paul Decuypere; Géraldine Gelders; Eric Lambie; Jeffrey Zielich; Johannes V Swinnen; Wim Annaert; Patrizia Agostinis; Bart Ghesquière; Steven Verhelst; Veerle Baekelandt; Jan Eggermont; Peter Vangheluwe
Journal:  Nature       Date:  2020-01-29       Impact factor: 49.962

2.  Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's disease.

Authors:  Dominic J Hare; Bárbara Rita Cardoso; Erika P Raven; Kay L Double; David I Finkelstein; Ewa A Szymlek-Gay; Beverley-Ann Biggs
Journal:  NPJ Parkinsons Dis       Date:  2017-01-05

Review 3.  Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies.

Authors:  Kenya Nishioka; Yuzuru Imai; Hiroyo Yoshino; Yuanzhe Li; Manabu Funayama; Nobutaka Hattori
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

Review 4.  Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.

Authors:  Xinglong Yang; Yanming Xu
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.